aTyr Pharma (LIFE) Announces Partner Kyorin Pharmaceutical, Co., Ltd. Proceeds to Phase 1 Trial of ATYR1923 in Japan

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/5/2026

1. KRG
2. ALAR
3. SPY
4. CCH:LN
5. META
6. CCHGY
7. PRY:IM
8. PRYMY
9. SKA-B
10. PBA

Go back to aTyr Pharma (LIFE) Announces Partner Kyorin Pharmaceutical, Co., Ltd. Proceeds to Phase 1 Trial of ATYR1923 in Japan

aTyr Pharma (LIFE) Tops Q2 EPS by 4c

August 13, 2020 4:04 PM EDT

aTyr Pharma (NASDAQ: LIFE) reported Q2 EPS of ($0.69), $0.04 better than the analyst estimate of ($0.73). Revenue for the quarter came in at $189 thousand versus the consensus estimate of $400 thousand.

While the advent of the global COVID-19 pandemic impacted our Phase 1b/2a clinical trial of ATYR1923 in... More